Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2017-01 Issue:10064 Volume:389 Page:56-66
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bruix Jordi,Qin Shukui,Merle Philippe,Granito Alessandro,Huang Yi-Hsiang,Bodoky György,Pracht Marc,Yokosuka Osamu,Rosmorduc Olivier,Breder Valeriy,Gerolami René,Masi Gianluca,Ross Paul J,Song Tianqiang,Bronowicki Jean-Pierre,Ollivier-Hourmand Isabelle,Kudo Masatoshi,Cheng Ann-Lii,Llovet Josep M,Finn Richard S,LeBerre Marie-Aude,Baumhauer Annette,Meinhardt Gerold,Han Guohong

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

2. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;Llovet;J Hepatol,2012

3. JSH Consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the Liver Cancer Study Group of Japan;Kudo;Liver Cancer,2014

4. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

Cited by 2918 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Therapies for Hepatocellular Carcinoma in India;Journal of Clinical and Experimental Hepatology;2024-11

2. Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma;Annals of Hepatology;2024-11

3. Anti-hepatoma immunotherapy of Pholiota adiposa polysaccharide-coated selenium nanoparticles by reversing M2-like tumor-associated macrophage polarization;International Journal of Biological Macromolecules;2024-10

4. Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials;Biomedicine & Pharmacotherapy;2024-10

5. Challenges related to clinical decision-making in hepatocellular carcinoma recurrence post-liver transplantation: Is there a hope?;World Journal of Transplantation;2024-09-18